NEW YORK (GenomeWeb News) – New England Biolabs today announced a manufacturing and supply agreement with molecular diagnostics firm Lumora.

NEB will manufacture and supply its Bst 2.0 DNA polymerase, a component of Lumora's bioluminescent assay in real time (BART) technology. The product is an in silico-designed homologue of Bacillus stearothermophilus DNA polymerase I, large fragment, NEB said on its website, and is used for isothermal amplification.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.